Literature DB >> 33511046

The Application of Traditional Chinese Medicine Against the Tumor Immune Escape.

Jing Xu1, Jingjing Zhang1, Jing Wang1.   

Abstract

Entities:  

Year:  2020        PMID: 33511046      PMCID: PMC7805287          DOI: 10.2478/jtim-2020-0032

Source DB:  PubMed          Journal:  J Transl Int Med        ISSN: 2224-4018


× No keyword cloud information.

Introduction

Tumor immune escape happens when tumor cells are not detected, recognized, and killed by the body’s immune system. It is often under the protection of the tumor microenvironment, which refers to a complex network composed of tumor cells, immune cells, endothelial cells, stromal cells, fibroblasts and various cytokines. By interacting with stromal cells and immune cells, or by secreting cytokines, tumor cells can get rid of the recognition and attack, and suppress the immune response of the host, so as to transform the tumor microenvironment into a microenvironment conducive to tumor survival, growth and uncontrollable proliferation, eventually causing immune escape of tumor cells.[ Among them, macrophages, dendritic cells, regulatory T cells, myeloid-derived suppressor cells and NK cells are the main immune regulatory cells. Traditional Chinese medicine (TCM), widely used by patients with cancers in China, can reverse the immune escape of tumor by modifying the microenvironment and enhancing the function of immune cells. According to TCM, the occurrence of tumor is related to the deficiency of healthy qi and the hyperactivity of evil qi in the body. It is the major principle of TCM in the treatment of malignant tumors to strengthen the healthy qi and disperse the evil qi, tonify the spleen and resolve the dampness, clear heat and detoxify. Strengthening the healthy qi and dispersing the evil qi method can play an anti-tumor role by regulating immune cell mediated tumor immune escape in tumor microenvironment. On the one hand, it can promote the secretion of tumor suppressor factors by macrophages, and inhibit the formation of tumor-related macrophages.[ Epimedium koreanum Nakai polysaccharides are an important active component of Epimedium. It can promote secretion of cytokines such as IFN-γ and TNF-α, and activate CD4+T cells differentiation to enhance the anti-tumor effect of the body.[ On the other hand, it can suppress the effect of myeloid derived suppressor cells (MDSCs) and reduce the angiogenesis of tumors. MDSCs are abundantly present in the tumor microenvironment, and are an important cell population that causes tumor immune escape and has immunosuppressive effects.[ By examining the level of MDSCs in peripheral blood of 31 breast cancer patients, it was found that the level of MDSCs in peripheral blood was closely related to disease progression. Shuganjianpi formula alone or combined with gemcitabine chemotherapy could inhibit the proliferation of MDSC cells and improve the immunity of the body.[ Many studies have repeatedly proven the key anti-cancer mechanism of TCM lies in regulating immune cells and mediating tumor immune escape. Pang et al.[ studied the mechanism of Bufei Decoction against Non-Small Cell Lung Cancer (NSCLC) and found that tumor-associated macrophages was essential in the progression of NSCLC and were related to tumor cell immune suppression. Su et al. [ established a mouse 4T1 breast cancer model and found that Xihuang Pill, a patent Chinese medicine of heat clearing and detoxification function, could promote apoptosis of Treg cells in the tumor microenvironment. Another study pointed out that Astragalus polysaccharide (APS), main component of qi tonifying herb Astragalus membranaceus, inhibited the expression of Foxp3 mRNA through cytokine and matrix repair, hampered SDF-1’s recruitment of Treg cells in the micro-environment of liver cancer, and reduces the immunosuppressive effect of Treg cells.[ Other research of Wolfberry, Scutellaria barbata, and Coix lacryma-jobi also showed their different properties to improve anti-tumor immunity.[ The wisdom of TCM method is in symphony with the most recent understanding of anti-cancer strategy. A comprehensive database of TCM on immuno-oncology has been established based on the chemical ingredients of herbs that interact with the immune-oncology targets.[ It provides us a new tool for potential herbs with immune regulating properties, yet all results need to be confirmed with further experiments and trials. Up to now, the scientific explanation of TCM for cancer is still rather preliminary. It calls for more rigorous experiments and clinical trials in order to decipher the capacity of TCM in the anti-tumor immunity.
  15 in total

Review 1.  Tumor microenvironment and therapeutic response.

Authors:  Ting Wu; Yun Dai
Journal:  Cancer Lett       Date:  2016-02-01       Impact factor: 8.679

2.  [Effects of Lycium barbarum polysaccharide on tumor microenvironment T-lymphocyte subsets and dendritic cells in H22-bearing mice].

Authors:  Yan-Li He; Yi Ying; Yan-Li Xu; Jun-Fang Su; Hui Luo; Hui-Feng Wang
Journal:  Zhong Xi Yi Jie He Xue Bao       Date:  2005-09

3.  Polysaccharides from Epimedium koreanum Nakai with immunomodulatory activity and inhibitory effect on tumor growth in LLC-bearing mice.

Authors:  Chengcheng Wang; Liang Feng; Jiayan Su; Li Cui; Jun Yan; Chuanlin Ding; Xiaobin Tan; Xiaobin Jia
Journal:  J Ethnopharmacol       Date:  2017-06-14       Impact factor: 4.360

4.  Effects of Shugan Jianpi Formula () on myeloid-derived suppression cells-mediated depression breast cancer mice.

Authors:  Yu-Tong Lu; Jie Li; Xin Qi; Ying-Xia Pei; Wen-Guang Shi; Hong-Sheng Lin
Journal:  Chin J Integr Med       Date:  2016-10-28       Impact factor: 1.978

5.  Polarized CD163+ tumor-associated macrophages are associated with increased angiogenesis and CXCL12 expression in gastric cancer.

Authors:  Jae-Young Park; Ji-Youn Sung; Juhie Lee; Yong-Koo Park; Youn Wha Kim; Gou Young Kim; Kyu Yeoun Won; Sung-Jig Lim
Journal:  Clin Res Hepatol Gastroenterol       Date:  2015-10-23       Impact factor: 2.947

6.  Xihuang pill promotes apoptosis of Treg cells in the tumor microenvironment in 4T1 mouse breast cancer by upregulating MEKK1/SEK1/JNK1/AP-1 pathway.

Authors:  Liang Su; Yiming Jiang; Yu Xu; Xinye Li; Wenbin Gao; Chunwei Xu; Changqian Zeng; Jie Song; Wencai Weng; Wenbo Liang
Journal:  Biomed Pharmacother       Date:  2018-04-05       Impact factor: 6.529

7.  Astragalus polysaccharides attenuate postburn sepsis via inhibiting negative immunoregulation of CD4+ CD25(high) T cells.

Authors:  Qing-yang Liu; Yong-ming Yao; Yan Yu; Ning Dong; Zhi-yong Sheng
Journal:  PLoS One       Date:  2011-06-15       Impact factor: 3.240

8.  Association between tumor-associated macrophages and microvessel density on prostate cancer progression.

Authors:  Prahara Yuri; Ahmad Zulfan Hendri; Raden Danarto
Journal:  Prostate Int       Date:  2015-07-28

9.  Norcantharidin combined with Coix seed oil synergistically induces apoptosis and inhibits hepatocellular carcinoma growth by downregulating regulatory T cells accumulation.

Authors:  Dan Wang; Chendong Yang; Zhuien Wang; Yi Yang; Defang Li; Xiaojie Ding; Wenjuan Xu; Qiusheng Zheng
Journal:  Sci Rep       Date:  2017-08-24       Impact factor: 4.379

10.  TCMIO: A Comprehensive Database of Traditional Chinese Medicine on Immuno-Oncology.

Authors:  Zhihong Liu; Chuipu Cai; Jiewen Du; Bingdong Liu; Lu Cui; Xiude Fan; Qihui Wu; Jiansong Fang; Liwei Xie
Journal:  Front Pharmacol       Date:  2020-04-15       Impact factor: 5.810

View more
  9 in total

1.  Inhalation of Salvianolic Acid B Prevents Fine Particulate Matter-Induced Acute Airway Inflammation and Oxidative Stress by Downregulating the LTR4/MyD88/NLRP3 Pathway.

Authors:  Yan Guan; Liucheng Li; Liandi Kan; Qiangmin Xie
Journal:  Oxid Med Cell Longev       Date:  2022-06-27       Impact factor: 7.310

2.  Lung adenocarcinoma-specific three-integrin signature contributes to poor outcomes by metastasis and immune escape pathways.

Authors:  Yizhe Wang; Kezuo Hou; Yue Jin; Bowen Bao; Shiying Tang; Jianfei Qi; Yang Yang; Xiaofang Che; Yunpeng Liu; Xuejun Hu; Chunlei Zheng
Journal:  J Transl Int Med       Date:  2021-12-31

3.  Lysionotin Induces Ferroptosis to Suppress Development of Colorectal Cancer via Promoting Nrf2 Degradation.

Authors:  Zhuo Gao; Junnan Jiang; Lijian Hou; Fujian Ji
Journal:  Oxid Med Cell Longev       Date:  2022-08-10       Impact factor: 7.310

4.  Case Report: Pulmonary sarcomatoid carcinoma complicating TP53 mutation treated successfully with Tislelizumab combined with Anlotinib-a case report.

Authors:  Yu-Feng Li; Xin-Fei Zhao; Yue Tian; Xin-Yao Xiao; Cai-Yun Yan; Hua Shen
Journal:  Front Genet       Date:  2022-07-22       Impact factor: 4.772

Review 5.  Harnessing the immune system by targeting immune checkpoints: Providing new hope for Oncotherapy.

Authors:  Lu Yu; Minghan Sun; Qi Zhang; Qiao Zhou; Yi Wang
Journal:  Front Immunol       Date:  2022-09-08       Impact factor: 8.786

Review 6.  Polysaccharide immunization and colorectal cancer: A systematic review and network meta-analysis.

Authors:  Yuefeng Chen; Xinnan Pan; Baoming Tian; Yajun Hu
Journal:  Front Nutr       Date:  2022-07-22

7.  Dose-Dependent Variation in Anticancer Activity of Hexane and Chloroform Extracts of Field Horsetail Plant on Human Hepatocarcinoma Cells.

Authors:  Hadeel A Almasoud; Daoud Ali; Khadijah N Yaseen; Hanouf Almukhlafi; Norah S Alothman; Bader Almutairi; Rafa Almeer; Nouf Alyami; Saad Alkahtani; Saud Alarifi
Journal:  Biomed Res Int       Date:  2022-06-25       Impact factor: 3.246

8.  Development and validation of cuproptosis-related gene signature in the prognostic prediction of liver cancer.

Authors:  Yanqing Liu; Yang Liu; Shujun Ye; Huijin Feng; Lianjun Ma
Journal:  Front Oncol       Date:  2022-08-12       Impact factor: 5.738

9.  Screening of ferroptosis-related genes with prognostic effect in colorectal cancer by bioinformatic analysis.

Authors:  Dongzhi Hu; Zhengyang Zhou; Junyi Wang; Kegan Zhu
Journal:  Front Mol Biosci       Date:  2022-09-20
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.